期刊文献+

天津地区近3年下呼吸道不动杆菌感染的临床和细菌耐药分析 被引量:2

Analysis on Antibiotic Resistance and Clinical Manifestations to Acinetobacter of the Lower Respiratory Tract Infection for three years in Tiainjin
下载PDF
导出
摘要 目的 :为了解天津地区下呼吸道不动杆菌感染的临床特点和对抗生素耐药情况。方法 :采用回顾性分析的方法 ,对天津地区10家医院2000年1月~2002年9月底呼吸科287例住院患者下呼吸道不动杆菌感染的临床和对抗生素耐药性进行了调查。结果 :天津地区3年来下呼吸道不动杆菌感染的特点为 :高龄老年多见72.2% ,有基础疾病者多见75.96 % ,曾使用抗生素者占59.23 % ,使用糖皮质激素4.53%。不动杆菌属药物敏感率在79.00 %以上的抗生素依次为亚胺培南、替卡西林、阿米卡星、头孢哌酮/舒巴坦、妥布霉素及左氧氟沙星等。对亚胺培南的耐药率最低5.8% ,其次为替卡西林9.2 %、头孢哌酮/舒巴坦10.0 %及阿米卡星11.4 %。对头孢噻吩、头孢唑啉、头孢呋辛、氨苄西林及氨曲南等抗生素的耐药率较高。结论 :下呼吸道不动杆菌感染的临床表现无特殊性 。 Objective:To investigate the clinical manifestations and the antibiotic resistance of Acinetobacter from the lower respiratory tract infection in Tianjin.Methods:The clinical data and the antibiotic resistance of the lower respiratory tract infection caused by Acinetobacter of287cases in respiratory department of10hosˉpital in Tianjin were reviewed from Jan.2000to Oct.2002.Results:The feature:Most of cases were the elder patients(72.2%),75.96%of cases had underling disease,59.23%were given broad-spectrum antibiotics,and4.53%were given glucocorticoid.Antibiotic sensitivity test in vitro showed that drugs with sensitive rate above79.00%included imipenem,ticarcillin,amikacin,cefoperazone/salbactam,tobramycin and levofloxacin.The resistant rate of Acinetobacter to imipenem was the lowest(5.8%),followed by ticarcillin(9.2%),cefoperaˉzone/salbactam(10.0%),amikacin(11.4%).The resistant rate of Acinetobacter was high to drugs such as cephalothin,cefazolin,cefuroxime,ampicillin and aztreouam.Conclusions:Clinical manifestations of the lower respiratory tract infection caused by Acinetobacter were no specificity,so the antibiotic uses should be selected according to the results of susceptibility test.
出处 《天津医科大学学报》 2004年第3期400-402,共3页 Journal of Tianjin Medical University
关键词 不动杆菌 抗生素敏感性 下呼吸道感染 Acinetobacter Antibiotic susceptibities The lower respiratory tract infection
  • 相关文献

参考文献4

二级参考文献16

  • 1Bergogne-Berezin E. Guideline on antimicrobial chemotherapy for prevention and treatment of infections in the ICU. J Chemother, 2001,1: 134-149.
  • 2Goossens H. MYSTIC program: summary of European data from 1997 to 2000. Diagn Microbiol Infect Dis, 2001, 41: 183-189.
  • 3Leblebicioglu H, Gunaydin M, Esen S, et al. Surveillance of antimicrobial resistance in gram-negative isolates from ICU in Turkey:analysis of data from the last 5 years. J Chemother, 2002, 14:140-146.
  • 4Karlowsky JA, Kelly LJ, Thornsberry C , et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000:TRUST and TSN data for the United States. J Autimicrob Agents , 2002,19: 21-31.
  • 5National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial susceptibility testing. Approved standard M100-S12. National Committee for Clinical Laboratory Standards,Wayne, Pa.2002,1.
  • 6Chanawong A. M' Zali FH, Heritage J, et al. Three cefotaximases,CTX-M-9, CTX-M-13, CTX-M-14, among Enterobacteriaceae in the People's Republic of China. Antimicrob Agents Chemother, 2002, 46:630-637.
  • 7陈吉泉,罗文侗,修清玉,沈策,颜泽敏.普通病房下呼吸道感染病原菌分布及耐药性研究[J].中华医院感染学杂志,2000,10(6):407-409. 被引量:71
  • 8陈晓燕.老年呼吸道感染临床分析[J].中华医院感染学杂志,2001,11(2):113-114. 被引量:68
  • 9陈哲,王彦,王燕,陈宝元,陈光瑾.非发酵菌在慢性肺心病患者下呼吸道感染中的变迁[J].中华医院感染学杂志,2001,11(4):312-313. 被引量:6
  • 10许航.危重病患者分离细菌来源及分布[J].中国急救医学,2001,21(8):461-462. 被引量:7

共引文献544

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部